| Literature DB >> 35910814 |
H Ceren Ates1,2, Peter Q Nguyen3, Laura Gonzalez-Macia4, Eden Morales-Narváez5, Firat Güder4, James J Collins3,6,7, Can Dincer1,2.
Abstract
Wearable devices provide an alternative pathway to clinical diagnostics by exploiting various physical, chemical and biological sensors to mine physiological (biophysical and/or biochemical) information in real time (preferably, continuously) and in a non-invasive or minimally invasive manner. These sensors can be worn in the form of glasses, jewellery, face masks, wristwatches, fitness bands, tattoo-like devices, bandages or other patches, and textiles. Wearables such as smartwatches have already proved their capability for the early detection and monitoring of the progression and treatment of various diseases, such as COVID-19 and Parkinson disease, through biophysical signals. Next-generation wearable sensors that enable the multimodal and/or multiplexed measurement of physical parameters and biochemical markers in real time and continuously could be a transformative technology for diagnostics, allowing for high-resolution and time-resolved historical recording of the health status of an individual. In this Review, we examine the building blocks of such wearable sensors, including the substrate materials, sensing mechanisms, power modules and decision-making units, by reflecting on the recent developments in the materials, engineering and data science of these components. Finally, we synthesize current trends in the field to provide predictions for the future trajectory of wearable sensors. © Springer Nature Limited 2022.Entities:
Keywords: Bioinspired materials; Biosensors; Diagnostic devices; Sensors and biosensors; Synthetic biology
Year: 2022 PMID: 35910814 PMCID: PMC9306444 DOI: 10.1038/s41578-022-00460-x
Source DB: PubMed Journal: Nat Rev Mater ISSN: 2058-8437 Impact factor: 76.679
Fig. 1Timeline of major milestones in the development of wearable sensors and a summary of their building blocks.
a | Major commercial and research-stage milestones in the development of wearable devices for health-care monitoring[10,12,13,28,99,244,283–288]. Advances in telecommunication technologies, materials science, bioengineering, electronics and data analysis, together with the rapidly increasing interest in monitoring health and well-being, have been the primary drivers of innovation in modern wearable sensors[148]. More recently, the considerable reductions in cost have enabled the penetration of modern wearable sensors into many segments of the (consumer) population and geographical regions of the world, unlocking continuous monitoring at a scale never seen before. In addition, advances in fabrication methods have enabled greater sophistication at increasingly smaller dimensions, enabling sensor platforms to reach scales amenable to integration into personal technologies. b | Building blocks of wearable devices, including the substrate and electrode materials and the components of the sensing, decision-making and power units. ISF, interstitial fluid. Panel b (on-tooth sensor) adapted from ref.[285], Springer Nature Limited.
Substrate materials
| Material class | Examples | Fabrication methods | Flexibility and elasticity (elastic modulus range) | Fabrication scalability | Functionalization | Biocompatibility | Sustainability | Refs. |
|---|---|---|---|---|---|---|---|---|
| Natural materials | Cotton, silk, wool, hemp, chitin | Weaving, knitting | Good (2–20 GPa)[ | High, with mature manufacturing processes | Poor | Excellent | Excellent | [ |
| Synthetic polymers | PDMS, silicone, PVA, PMMA, polyimide, rubber | Weaving, knitting, casting, photolithography, mechanical punching, lamination, extrusion, layer-by-layer assembly | Excellent (0.25 MPa to 3.5 GPa)[ | High, with mature manufacturing processes | Excellent, with various functionalization chemistries | Fair | Poor | [ |
| Hydrogels | Alginate, agarose, PEG, PHEMA, polyacrylamide, PVA | Casting, photolithography, mechanical punching | Excellent (1 kPa to 10 MPa)[ | Fair | Excellent, with various functionalization chemistries | Excellent | Poor, with the exception of naturally derived polymers | [ |
| Inorganic materials | Copper, gold, silver, platinum, chromium, graphene, gold NPs, silver NPs, silver NWs, carbon nanotubes | Wet etching, deposition, screen printing, lamination | Fair (73 GPa to 2.4 TPa)[ | Poor | Fair | Poor | Poor | [ |
NP, nanoparticle; NW, nanowire; PDMS, polydimethylsiloxane; PEG, polyethylene glycol; PHEMA, poly-(2-hydroxyethyl methacrylate); PMMA, polymethyl methacrylate; PVA, polyvinyl alcohol.
Comparison and characteristics of biofluids
| Biofluid | Target biomarkers | Sampling volume | Sampling methods | Wearable format | Demonstrated diagnostic examples | Advantages | Disadvantages | Refs. |
|---|---|---|---|---|---|---|---|---|
| Interstitial fluid | Metabolites, electrolytes, metals, proteins, peptides, amino acids, fatty acids, coenzymes, hormones, neurotransmitters, circulating RNAs | Low (1–10 ml) | Microneedle patches, reverse iontophoresis | On-skin patch | Metabolite detection: glucose, lactate, ketone bodies, alcohol and uric acid pH sensing Neurotransmitter detection Drug monitoring | Rich source of biomarkers Location (near the skin surface) ideal for wearable devices | Sampling is invasive Discomfort from sampling approaches Low sample volume for analysis Lag between blood and interstitial analyte levels Skin thickness variation between sites and individuals | [ |
| Sweat | Metabolites, electrolytes, metals, proteins, hormones, neurotransmitters, peptides, fatty acids | Low to medium (1–100 ml) | Reverse iontophoresis, capillary wicking | On-skin patch, tattoos | Metabolite detection: glucose, lactate, alcohol and uric acid Protein biomarker detection: IL-1β, IL-6, IL-8, TNF, CRP Hormone detection: cortisol, neuropeptide Y Chronic disease monitoring: cystic fibrosis, inflammatory bowel disease | Convenient non-invasive sample source Location (on the skin surface) ideal for wearable devices | Low volumes at normal sweat rates Evaporative loss Contamination Dilute analyte concentrations Variation in sweating rates Compositional variation depending on the area of sampling | [ |
| Breath | Metabolites (volatilized or in aerosols); bacteria and viruses | Very low (1–10 ml, as aerosols) | Aerosol capture or condensation | Face mask | Metabolite detection: hydrogen peroxide SARS-CoV-2 testing | Convenient non-invasive sample source Sample continuously generated | Limited biomarkers, with the exception of VOCs Requires wearable device integration into a face mask, which might be uncomfortable for user Unique sampling requirements for aerosol capture VOC detection would require notable sensor engineering | [ |
| Tear fluid | Metabolites, electrolytes, proteins, hormones, lipids | Low (1–10 ml) | Direct contact or immersion | Contact lens | Metabolite detection: glucose and lactate | Convenient non-invasive sample source Sample continuously secreted | Location on the eye requires considerable device engineering Lag between blood and tear analyte levels Correlation between blood and tear analyte might be weak | [ |
| Saliva | Metabolites, electrolytes, proteins, hormones, bacteria and viruses | High (1–10 ml; average total daily output is ~1 l) | Direct contact or immersion | Mouthguard, on-tooth patch | Metabolite detection: glucose, lactate, alcohol and uric acid Specific bacterial monitoring Drug and hormone testing | Convenient non-invasive sample source Sample continuously secreted | High viscosity might pose sampling problems Variation in analyte correlation between blood and saliva Changes in saliva production due to talking, eating or drinking Contamination due to eating or drinking Form factor for comfortable long-term use | [ |
| Urine | Metabolites, electrolytes, metals, toxins, proteins, peptides, amino acids, fatty acids, coenzymes, hormones, neurotransmitters, circulating RNA and DNA | High (hundreds of millilitres; average total daily output is 0.8–2 l) | Direct contact or immersion | Diaper | Metabolite detection: glucose, nitrate pH sensing | Rich source of biomarkers Convenient non-invasive sample source | Applications in wearables limited to urination events | [ |
CRP, C-reactive protein; IL, interleukin; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; TNF, tumour necrosis factor; VOC, volatile organic compound.
Biorecognition elements
| Biorecognition element | Recognized analytes | Detection mode | Synthesis approach | Inherent amplification | Chemical functionalization | Continuous measurement | Advantages | Disadvantages | Refs. |
|---|---|---|---|---|---|---|---|---|---|
| Enzymes | Metabolites, small molecules | Catalysis | Natural or recombinant production | Yes | Poor | Good | Many enzymes are available for metabolites and substrates; can be extremely sensitive | Stability might be a concern | [ |
| Affinity proteins | Metabolites, small molecules, proteins, peptides, nucleic acids, lipids | Direct binding | Natural or recombinant production | No | Poor | Poor | Many affinity proteins are available and well-developed assays for them exist; can be extremely sensitive | Stability might be a concern; considerable effort to create a novel affinity protein | [ |
| Affinity peptides | Proteins, peptides, nucleic acids, materials | Direct binding | Chemical synthesis | No | Good | Good | Small size; chemical synthesis enables a wide range of functionalizations; very stable | Can exhibit poor sensitivity and specificity | [ |
| Aptamers | Metabolites, small molecules, proteins, peptides, nucleic acids, lipids | Direct binding | In vitro synthesis or chemical synthesis | No | Good | Good | Chemical synthesis enables a wide range of functionalizations; some aptamers can be reversibly unfolded | Stability might be a concern owing to nucleases; might require considerable effort to create a novel aptamer | [ |
| CRISPR | Nucleic acids | Direct binding or catalysis | Natural or recombinant production | Yes: Cas12, Cas13 and Cas14 only | Poor | Poor | Easy to use; highly programmable for nucleic acid targeting | Probe molecules needed for CRISPR sensing are labile owing to nucleases in sample | [ |
Examples of combining data-driven methods with wearables for health-care applications
| Application | Wearables | Measured parameters | ML method | Number of participants in study | Unobtrusive?a | Refs. |
|---|---|---|---|---|---|---|
| Glucose-level prediction | Dexcom G6+ | Interstitial glucose concentration, electrodermal activity, skin temperature, activity | DT | 16 | Yes, at home | [ |
| Dexcom C4, Dexcom C7 plus, Medtronic iPro2 | Glucose concentration | NN | 278 | Yes, with follow-up visits | [ | |
| Abbott FreeStyle Libre | Glucose concentration | ARIMA, RF, SVM | 25 | Yes | [ | |
| Epilepsy management | Empatica E4 | Motor seizures | DNN-LSTM | 38 | No, in controlled environment | [ |
| Face action, fatigue and drowsiness monitoring | Eyeglass platform with accelerometer, gyroscope and electrooculography sensors | Facial action detection, blinks, percentage of eye closure | CNN, LR | 17 | No, in controlled environment | [ |
| Parkinson disease | Six Opal IMU sensors | Balance and gait features | NN, SVM, kNN, DT, RF, GB, LR | 524 patients with Parkinson disease and 43 patients with essential tremor | No, in controlled environment | [ |
| Great Lakes NeuroTechnologies wrist and ankle accelerometers | Free movement gyroscope data | Ensemble methods (LSTM, 1D CNN-LSTM, 2D CNN-LSTM) | 24 | No, in controlled environment | [ | |
| Mood disorder | Mi Band 2 supported with clinician report, self-report and smartphone use log through app | Daily phone usage, sleep data, step count data, self-evaluated mood scores of the user | SVM, RF, kNN | 334 | Yes, with follow-up visits | [ |
| Respiratory disorders and diseases | Two wireless wearables attached to the chest (non-commercial) | Respiratory behaviours | RF | 11 | No, in controlled environment | [ |
| SARS-CoV-2 detection | Fitbit | Heart rate, activity data | LAAD | 25 patients positive for COVID-19, 11 patients negative for COVID-19 and 70 healthy individuals | Yes | [ |
| Everion Biofourmis | Heart rate, heart rate variability, respiration rate, oxygen saturation, blood pulse wave, skin temperature, actigraphy | LVR | 34 patients positive for COVID-19 | No, in controlled environment | [ |
ARIMA, autoregressive integrated moving average; CNN, convolutional neural network; DNN, deep neural network; DT, decision tree; GB, gradient boosting classifier; IMU, inertial measurement unit sensor; kNN, k-nearest neighbours; LAAD, LSTM-based autoencoder for anomaly detection; LR, logistic regression; LSTM, long short-term memory; LVR, linear vector regression; ML, machine learning; NN, neural network; RF, random forest; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; SVM, support-vector machines. aUnobstrusive collection and analysis of data from the participant under study. Testing wearable devices within an unobtrusive analysis might reduce biases, as it reflects the natural behaviours of test participants in their daily life.
Fig. 2The decision-making unit and its working principles.
a | Conceptualization of the data pipeline. The combination and processing of multiple wearables with multiple sensing strategies provides access to physiologically relevant parameters and biomarkers to better explain the non-linearity in human physiology. The black and red lines indicate the data processing and model training pathways, respectively. b | Overview of data-driven methods. Post-processing of big data to explore the complex links between the measured signals and physiological status of individuals is possible with machine learning algorithms. ANN, artificial neural network; DT, decision tree; GDBSCAN, generalized density-based spatial clustering of applications with noise; GM, Gaussian means; HC, hierarchical clustering; kNN, k-nearest neighbours; RF, random forest; SVM, support-vector machines. Panel a (top part) adapted from ref.[14], Springer Nature Limited.
Fig. 3Energy harvesting methods.
a | Piezoelectricity is generated by mechanical motion, which activates a piezoelectric material. b | Triboelectricity is produced by motion that results in the physical contact and separation of two materials with different electronegativities. c | Thermoelectricity is generated when the surface of conductor A is heated and this energy is then transferred to conductor B, which triggers the motion of charge carriers (such as electrons and holes) and generates a voltage. d | Photovoltaic energy is generated when a photovoltaic material is irradiated with light. e | Electromagnetic radiation is managed by antennas that transform electromagnetic waves into a voltage or current. f | Wearable biofuel cells create energy from a catalytic reaction, which occurs between the fuel provided by a biofluid (such as sweat) and an enzyme; the reaction is generally enhanced by a mediator that boosts the electron transfer process between the enzymes and the electrodes.